计算溶液所需的质量、体积或浓度。
卡萨霉素B 是瘦链霉菌素复合物的次要成分,该复合物是由a.Streptomyces sp。|的肉汤发酵产生的。该化合物是Leptomycin A的羟基化类似物,它是一种核输出抑制剂,且具有高度亲脂性。| 卡萨霉素B 对肿瘤L1210,P388 / S,B16,HeLa S3,L5178Y-ML或当在卡祖霉素B存在下培养72小时时,确定L929的IC 50为1.8、2.0、0.7、1.8、10.0和1.0ng / ml。该化合物在小鼠中还表现出广泛的抗肿瘤活性,其有效性比体内和体外给药浓度更依赖于给药方案。
Kazusamycin B is a minor component of the leptomycin complex produced from the fermentation of the broth of a|Streptomyces sp.|. The compound is a hydroxylated analogue of Leptomycin A , a nuclear export inhibitor, and highly lipophillic.|In vitro|antitumor activity of Kazusamycin B on tumors L1210, P388/S, B16, HeLa S3, L5178Y-ML or L929 was ascertained to have an IC|50|of 1.8, 2.0, 0.7, 1.8, 10.0 and l.0 ng/ml when cultured in the presence of Kazusamycin B for 72 hours. The compound has also displayed broad antitumor activity in mice with effectiveness being more dependent on dosing regimen than dosing concentration both|in vivo|and|in vitro|. Kazusamycin B also possesses antibacterial and antifungal activity.
| IC50 | B16: IC₅₀= 0.7 ng/ml; L929: IC₅₀= 1.0 ng/ml; Tumors L1210: IC₅₀= 1.8 ng/ml; HeLa S3: IC₅₀= 1.8 ng/ml; P388/S: IC₅₀= 2.0 ng/ml |
|---|
P264: 处理后要彻底洗手。